Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Solasia to Start China Clinical Trial of Anti-Nausea Patch Product

publication date: Feb 5, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Solasia, a Japan-headquartered company, has received a Clinical Trial Permit from the SFDA for China trials of Sancuso®, the company’s transdermal patch product for the treatment of chemotherapy-induced nausea and vomiting. Solasia in-licensed rights to Sancuso® for Southeast Asia in 2008 from a British pharma, ProStrakan. Solasia will begin a trial of the product immediately and expects to file a New Drug Application in China during Q4 of 2013. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners